Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

Overview of attention for article published in Journal of Hematology & Oncology, September 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 86 Dimensions

Readers on

mendeley: 36 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 86 publications that cite this research output.

86

The most recent citing publications are shown below. View all 86 publications that cite this research output on Dimensions.

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?

Article in Hematology (April 2024)

Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial

Article in BMC Medicine (February 2024)

Low dose post-transplant cyclophosphamide and sirolimus induce mixed chimerism with CTLA4-Ig or lymphocyte depletion in an MHC-mismatched murine allotransplantation model

Article in Bone Marrow Transplantation (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.